Herforth C, Zimmern PE. Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report.
Case Rep Womens Health 2024;
43:e00649. [PMID:
39314984 PMCID:
PMC11418125 DOI:
10.1016/j.crwh.2024.e00649]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2024] [Revised: 09/03/2024] [Accepted: 09/04/2024] [Indexed: 09/25/2024] Open
Abstract
Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.
Collapse